Standard management of patients with chronic myeloid leukemia.

Clinical lymphoma & myeloma

Volumn 9 Suppl 4, Issue , 2009, Pages

  Fava, Carmen ^a   Cortés, Jorge E ^a   Kantarjian, Hagop ^a   Jabbour, Elias ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; IMATINIB; PIPERAZINE DERIVATIVE; PROTEIN KINASE INHIBITOR; PYRIMIDINE DERIVATIVE;

CHRONIC MYELOID LEUKEMIA; CLINICAL TRIAL; DRUG RESISTANCE; HUMAN; REVIEW;

ANTINEOPLASTIC AGENTS; CLINICAL TRIALS AS TOPIC; DRUG RESISTANCE, NEOPLASM; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; PIPERAZINES; PROTEIN KINASE INHIBITORS; PYRIMIDINES;

MLCS; MLOWN;

EID: 77949474988     PISSN: None     EISSN: 19380712     Source Type: Journal    
DOI: 10.3816/clm.2009.s.038     Document Type: Review

References (93)